172 related articles for article (PubMed ID: 34379433)
1. Blood-Brain Barrier Crossing Renin-Angiotensin System Drugs: Considerations for Dementia and Cognitive Decline.
Glodzik L; Santisteban MM
Hypertension; 2021 Sep; 78(3):644-646. PubMed ID: 34379433
[No Abstract] [Full Text] [Related]
2. Renin-angiotensin system blockade use and risks of cognitive decline and dementia: A meta-analysis.
Zhuang S; Wang HF; Li J; Wang HY; Wang X; Xing CM
Neurosci Lett; 2016 Jun; 624():53-61. PubMed ID: 27163195
[TBL] [Abstract][Full Text] [Related]
3. Modulation of Renin-Angiotensin System May Slow Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
Wharton W; Goldstein FC; Zhao L; Steenland K; Levey AI; Hajjar I
J Am Geriatr Soc; 2015 Sep; 63(9):1749-56. PubMed ID: 26389987
[TBL] [Abstract][Full Text] [Related]
4. The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer's disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status.
Ouk M; Wu CY; Rabin JS; Jackson A; Edwards JD; Ramirez J; Masellis M; Swartz RH; Herrmann N; Lanctôt KL; Black SE; Swardfager W
Alzheimers Res Ther; 2021 Feb; 13(1):43. PubMed ID: 33573702
[TBL] [Abstract][Full Text] [Related]
5. Renin-angiotensin system-targeting antihypertensive drugs and risk of vascular cognitive impairment: A meta-analysis.
Zhuang S; Li J; Wang X; Wang HF; Zhang WJ; Wang HY; Xing CM
Neurosci Lett; 2016 Feb; 615():1-8. PubMed ID: 26797651
[TBL] [Abstract][Full Text] [Related]
6. Renin Angiotensin aldosterone system inhibition in controlling dementia-related cognitive decline.
O'Caoimh R; Kehoe PG; Molloy DW
J Alzheimers Dis; 2014; 42 Suppl 4():S575-86. PubMed ID: 25182739
[TBL] [Abstract][Full Text] [Related]
7. Chronic Renin-Angiotensin System Activation Induced Neuroinflammation: Common Mechanisms Underlying Hypertension and Dementia?
Tran S; Kuruppu S; Rajapakse NW
J Alzheimers Dis; 2022; 85(3):943-955. PubMed ID: 34897090
[TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies.
Anderson C; Teo K; Gao P; Arima H; Dans A; Unger T; Commerford P; Dyal L; Schumacher H; Pogue J; Paolasso E; Holwerda N; Chazova I; Binbrek A; Young J; Yusuf S;
Lancet Neurol; 2011 Jan; 10(1):43-53. PubMed ID: 20980201
[TBL] [Abstract][Full Text] [Related]
9. Arterial Blood Pressure Variability and Other Vascular Factors Contribution to the Cognitive Decline in Parkinson's Disease.
Pierzchlińska A; Kwaśniak-Butowska M; Sławek J; Droździk M; Białecka M
Molecules; 2021 Mar; 26(6):. PubMed ID: 33802165
[TBL] [Abstract][Full Text] [Related]
10. [Brain renin-angiotensin-aldosterone system and cognitive function].
Horiuchi M
Nihon Rinsho; 2014 Apr; 72(4):641-7. PubMed ID: 24796091
[TBL] [Abstract][Full Text] [Related]
11. AT1 Receptors: Their Actions from Hypertension to Cognitive Impairment.
Wu H; Sun Q; Yuan S; Wang J; Li F; Gao H; Chen X; Yang R; Xu J
Cardiovasc Toxicol; 2022 Apr; 22(4):311-325. PubMed ID: 35211833
[TBL] [Abstract][Full Text] [Related]
12. Renin-angiotensin-aldosterone system has a pivotal role in cognitive impairment.
Yagi S; Akaike M; Ise T; Ueda Y; Iwase T; Sata M
Hypertens Res; 2013 Sep; 36(9):753-8. PubMed ID: 23698805
[TBL] [Abstract][Full Text] [Related]
13. The renin-angiotensin system, hypertension and cognitive dysfunction in Alzheimer's disease: new therapeutic potential.
Takeda S; Sato N; Ogihara T; Morishita R
Front Biosci; 2008 Jan; 13():2253-65. PubMed ID: 17981707
[TBL] [Abstract][Full Text] [Related]
14. Treatment options and considerations for hypertensive patients to prevent dementia.
Hernandorena I; Duron E; Vidal JS; Hanon O
Expert Opin Pharmacother; 2017 Jul; 18(10):989-1000. PubMed ID: 28532183
[TBL] [Abstract][Full Text] [Related]
15. Blood-brain barrier disturbances in diabetes-associated dementia: Therapeutic potential for cannabinoids.
Brook E; Mamo J; Wong R; Al-Salami H; Falasca M; Lam V; Takechi R
Pharmacol Res; 2019 Mar; 141():291-297. PubMed ID: 30616019
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in the Endogenous Brain Renin-Angiotensin System and Drugs Acting on It.
Urmila A; Rashmi P; Nilam G; Subhash B
J Renin Angiotensin Aldosterone Syst; 2021; 2021():9293553. PubMed ID: 34925551
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic angiotensin type 1 receptor antagonism confers neuroprotection in an aged rat model of postoperative cognitive dysfunction.
Li Z; Cao Y; Li L; Liang Y; Tian X; Mo N; Liu Y; Li M; Chui D; Guo X
Biochem Biophys Res Commun; 2014 Jun; 449(1):74-80. PubMed ID: 24814703
[TBL] [Abstract][Full Text] [Related]
18. Renin-dependent cardiovascular functions and renin-independent blood-brain barrier functions revealed by renin-deficient mice.
Yanai K; Saito T; Kakinuma Y; Kon Y; Hirota K; Taniguchi-Yanai K; Nishijo N; Shigematsu Y; Horiguchi H; Kasuya Y; Sugiyama F; Yagami Ki; Murakami K; Fukamizu A
J Biol Chem; 2000 Jan; 275(1):5-8. PubMed ID: 10617578
[TBL] [Abstract][Full Text] [Related]
19. Sex, Drugs, and Adverse Drug Reactions: Sex Differences in Laboratory Monitoring Outcomes After Initiation of Renin-Angiotensin-Aldosterone-System Inhibition Therapy.
Dumanski SM; Ahmed SB
Circ Cardiovasc Qual Outcomes; 2020 Sep; 13(9):e007045. PubMed ID: 32873053
[No Abstract] [Full Text] [Related]
20. Leaky memories: Impact of
Li W; Lo EH
J Cereb Blood Flow Metab; 2020 Sep; 40(9):1912-1914. PubMed ID: 32600092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
